DK Life Science Co., Ltd. (KOSDAQ: A303810)
Health Care · Pharmaceuticals · KR
₩2,650.00
-5.53% today · -33.8% 1Y
DK Life Science Co., Ltd. (KOSDAQ: A303810) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $63.05M.
Over the last twelve months the share price has lost 33.8%, trading between 2.15K and 4.16K.
Tweenvest scores DK Life Science Co., Ltd. across four factors: quality 67/100, value 54/100, growth 38/100. Its strongest factor is quality.
A303810 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $63.05M
- Revenue (TTM)
- $76.03M
- P/E
- 17.02
- EPS
- 155.66
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩4,160.00
- 52-week low
- ₩2,155.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.98M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TSH Biopharm Corporation LimitedTPEX: 8432 | $63.89M | NT$53.20 | +4.11% |
| Sam-A Pharm. Co., LtdKOSDAQ: A009300 | $63.47M | ₩13,980.00 | +0.94% |
| Pliant Therapeutics, Inc.NasdaqGS: PLRX | $63.16M | $0.99 | -2.93% |
| Choong Ang Vaccine Laboratory Co., Ltd.KOSDAQ: A072020 | $63.07M | ₩9,160.00 | +0.11% |
| Recce Pharmaceuticals LtdASX: RCE | $62.95M | AU$0.30 | -9.23% |
| InterCure Ltd.TASE: INCR | $62.72M | ₪16.22 | -3.97% |
| The Arab Drug CompanyCASE: ADCI | $62.33M | EGP272.01 | +0.00% |
| LTR Pharma LimitedASX: LTP | $61.69M | AU$0.49 | +3.19% |
Figures last refreshed Oct 11, 2026.